Top

Published in:

01-12-2001 | Current Opinion

Using Humanistic Health Outcomes Data in Asthma

Author: Professor Elizabeth F. Juniper

Published in: PharmacoEconomics | Special Issue 2/2001

Abstract

One of the aims of treatment of asthma is to improve patient well-being,which incorporates the concept of patients’ perceptions of how they feel and their ability to function in their everyday life [health-related quality of life (HR-QOL)]. The weak association between conventional measures of clinical status in asthma and asthma-specific quality of life means that quality of life must be measured directly — it cannot be inferred from clinical measures. HR-QOL is measured using instruments which elicit information from patients about the impact of the disease and its treatment on both their physical and emotional functioning. Such instruments may be generic (used for all diseases) or specific to a particular group of patients, function or disease. Disease-specific quality-of-life questionnaires are useful in clinical trials and practice because they are more responsive to small but clinically important changes than generic instruments. Generic instruments provide an estimate of the patients’ burden of illness that can be compared with the burden experienced by patients with other medical conditions. Consequently, HR-QOL should be included as an outcome measure in all assessments of asthma.

Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers, 1996: 11–23

Guyatt GH, Naylor D, Juniper EF, et al. Users’ guides to the medical literature. IX. How to use an article about health-related quality of life. The Evidence-Based Medicine Working Group. JAMA 1997; 277: 1232–7PubMedCrossRef

Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76–83PubMedCrossRef

Juniper EF, Johnston PR, Borkhoff CM, et al. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995; 151: 66–70PubMed

Rutten–van Mölken MP, Custers F, Van Doorslaer EK, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995; 8: 888–98PubMed

Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993; 148: 675–81PubMedCrossRef

Leidy NK, Coughlin C. Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample. Qual Life Res 1998; 7: 127–34PubMedCrossRef

Juniper EF, Svensson K, O’Byrne PM, et al. Asthma quality of life during one year of treatment with budesonide with or without formoterol. Eur Respir J 1999; 14: 1038–43PubMedCrossRef

Juniper EF, Buist AS. Health-related quality of life in moderate asthma: 400μg hydrofluoroalkane beclomethasone dipropionate vs 800μg chlorofluorocarbon beclomethasone dipropionate. The study group. Chest 1999; 116: 1297–303PubMedCrossRef

10.

Juniper EF, Guyatt GH, Ferrie PJ, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832–8PubMed

11.

Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992; 45: 461–72PubMedCrossRef

12.

Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J Psychosom Res 1991; 35: 99–110PubMedCrossRef

13.

Quirk FH, Baveystock CM, Wilson R, et al. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. Eur Respir J 1991; 4: 167–71PubMed

14.

Maille AR, Kaptein AA, Koning CJ, et al. Developing a quality- of-life questionnaire for patients with respiratory illness. Monaldi Arch Chest Dis 1994; 49: 76–8PubMed

15.

Creer TL, Wigal JK, Kotses H, et al. A life activities questionnaire for adult asthma. J Asthma 1992; 29: 393–915PubMedCrossRef

16.

Malo JL, Boulet LP, Dewitte JD, et al. Quality of life of subjects with occupational asthma. J Allergy Clin Immunol 1993; 91: 1121–7PubMedCrossRef

17.

Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in children with asthma. Qual Life Res 1996; 5: 35–46PubMedCrossRef

18.

Townsend M, Feeny DH, Guyatt GH, et al. Evaluation of the burden of illness for pediatric asthmatic patients and their parents. Ann Allergy 1991; 67: 403–8PubMed

19.

Creer TL, Wigal JK, Kotses H, et al. A life activities questionnaire for childhood asthma. J Asthma 1993; 30: 467–73PubMedCrossRef

20.

Christie MJ, French D, Sowden A, et al. Development of childcentered disease-specific questionnaires for living with asthma. Psychosom Med 1993; 55: 541–8PubMed

21.

Nocon A. Social and emotional impact of childhood asthma. Arch Dis Child 1991; 66: 458–60PubMedCrossRef

22.

Usherwood TP, Scrimgeour A, Barber JH. Questionnaire to measure perceived symptoms and disability in asthma. Arch Dis Child 1990; 65: 779–81PubMedCrossRef

23.

Osman L, Silverman M. Measuring quality of life for young children with asthma and their families. Eur Respir J Suppl. 1996; 21: 35s–41PubMed

24.

Guyatt GH, Juniper EF, Feeny DH, et al. Children and adult perceptions of childhood asthma. Pediatrics 1997; 99: 165–8PubMedCrossRef

25.

Rosenbaum PL, Saigal S. Measuring health–related quality of life in pediatric populations: conceptual issues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippencott-Raven Publishers, 1996: 785–91

26.

Wood PR, Hidalgo HA, Prihoda TJ, et al. Comparison ofHispanic children’s and parents’ responses to questions about the child’s asthma. Arch Pediatr Adolesc Med 1994; 148: 43CrossRef

27.

Theunissen NC, Vogels TG, Koopman HM, et al. The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res 1998; 7: 387–97PubMedCrossRef

28.

Juniper EF, Guyatt GH, Feeny DH, et al. Minimum skills required by children to complete health-related quality of life instruments: comparison of instruments for measuring asthma-specific quality of life. Eur Respir J 1997; 10: 2285–94PubMedCrossRef

29.

Juniper EF, Howland WC, Roberts NB, et al. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998; 101: 163–70PubMedCrossRef

30.

Stewart AL, Hays R, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724–32PubMedCrossRef

31.

Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787–805PubMedCrossRef

32.

Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994; 149 (2 Pt 1): 371–5PubMed

33.

Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94 (2 Pt 1): 182–8PubMedCrossRef

34.

Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995; 113: 104–9PubMedCrossRef

35.

Juniper EF, Norman GR, Cox FM, et al. Comparison of the standard gamble rating scale AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001; 18: 1–7CrossRef

36.

Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1–30PubMedCrossRef

37.

Kaplan RM, Anderson JP, Wu AW, et al. The Quality of Wellbeing Scale: application in AIDS, cystic fibrosis and arthritis. Med Care 1989; 27: S27–43PubMedCrossRef

38.

Feeny D, Furlong W, Barr RD, et al. Acomprehensive multi-attribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 1992; 10: 923–8PubMed

39.

EuroQol — a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199–208

40.

Juniper EF, Buist AS, Cox FM, et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999; 115: 1265–70PubMedCrossRef

41.

Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of theMini Asthma Quality of Life Questionnaire. Eur Respir J 1999; 14: 32–8PubMedCrossRef

42.

Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81–7PubMedCrossRef

43.

Guyatt GH, Juniper EF, Walter SD, et al. Interpreting treatment effects in randomised trials. BMJ 1998; 101: 163–70

44.

Grossman PR, Stanford RH, Edwards L, et al. The impact of fluticasone propionate compared to zafirlukast on asthma related quality of life. Am J Respir Crit Care Med 2000; 161 (3): 788

45.

Reese PR, Mather DB, Mahajan P, et al. Combination of salmeterol/fluticasone propionate via Diskus improves quality of life in asthma patients. J Allergy Clin Immunol 103 (1 Pt 2): S69

Title: Using Humanistic Health Outcomes Data in Asthma
Author: Professor Elizabeth F. Juniper
Publication date: 01-12-2001
Publisher: Springer International Publishing
Published in: PharmacoEconomics / Issue Special Issue 2/2001
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI: https://doi.org/10.2165/00019053-200119002-00003

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Using Humanistic Health Outcomes Data in Asthma

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2001

Using Clinical Measures of Disease Control to Reduce the Burden of Asthma

The Way Forward in the Care of Respiratory Diseases

Using Health Outcomes Data to Inform Decision-Making

Using Health Outcomes Data to Inform Decision-Making

Using Health Outcomes Data to Inform Decision-Making

The Burden of Asthma and Chronic Obstructive Pulmonary Disease